High neutralizing potency of swine glyco‐humanized polyclonal antibodies against SARS‐CoV‐2
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Immunology"
DOI: 10.1002/eji.202049072
Abstract: Heterologous polyclonal antibodies might represent an alternative to the use of convalescent plasma or monoclonal antibodies (mAbs) in coronavirus disease (COVID‐19) by targeting multiple antigen epitopes. However, heterologous antibodies trigger human natural xenogeneic antibody responses… read more here.
Keywords: glyco humanized; humanized polyclonal; sars cov; polyclonal antibodies ... See more keywords
LIS1, a glyco-humanized swine polyclonal anti-lymphocyte globulin, as a novel induction treatment in solid organ transplantation
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1137629
Abstract: Anti-thymocyte/lymphocyte globulins (ATGs/ALGs) are immunosuppressive drugs used in induction therapies to prevent acute rejection in solid organ transplantation. Because of animal origin, ATGs/ALGs contain highly immunogenic carbohydrate xenoantigens eliciting antibodies that are associated with subclinical… read more here.
Keywords: organ transplantation; lymphocyte; transplantation; induction treatment ... See more keywords
Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1208705
Abstract: [This corrects the article DOI: 10.3389/fimmu.2021.761250.]. read more here.
Keywords: swine glyco; humanized polyclonal; xav swine; polyclonal antibody ... See more keywords